Pnc Financial Services »

Aim Immunotech shares owned by Pnc Financial Services

Quarter-by-quarter ownership of Aim Immunotech (AIM) shares owned by Pnc Financial Services from 13F filings

Historical chart of Pnc Financial Services investment in Aim Immunotech

Tip: Access up to 7 years of quarterly data

All positions including Aim Immunotech held by Pnc Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aim Immunotech by Pnc Financial Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $137 50 2.74

More positions owned by Pnc Financial Services

Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Et (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Erie Indty Cl A (ERIE)
Amazon (AMZN)
Ishares Tr Rus 1000 Grw E (IWF)
Ishares Tr Core Msci Eafe (IEFA)
Wisdomtree Tr Us Qtly Div Gr (DGRW)

View all positions for Pnc Financial Services

Top funds holding Aim Immunotech

DRW Holdings
Sabby Management
Vanguard Group
Geode Capital Management
Morgan Stanley
UBS Group
Community Bank
Pnc Financial Services
Advisor Group Holdings
Hoey Investments
Harbour Investments
Wells Fargo & Company
Steward Partners Investment Advisory
Farther Finance Advisors

View all funds holding Aim Immunotech